PTC Therapeutics
PTCT
PTCT
164 hedge funds and large institutions have $1.66B invested in PTC Therapeutics in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 70 increasing their positions, 48 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
24% less capital invested
Capital invested by funds: $2.2B → $1.66B (-$536M)
25% less call options, than puts
Call options by funds: $11.9M | Put options by funds: $15.8M
46% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 35
Holders
164
Holding in Top 10
6
Calls
$11.9M
Puts
$15.8M
Top Buyers
| 1 | +$47.2M | |
| 2 | +$45.2M | |
| 3 | +$26.3M | |
| 4 |
Renaissance Technologies
New York
|
+$25.4M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$20.2M |
Top Sellers
| 1 | -$46.4M | |
| 2 | -$32.9M | |
| 3 | -$26.1M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$23.5M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$11.1M |